| Dr Matthew Labarbera, MD | |
|
551 Lone Pine Blvd, The Dalles, OR 97058-9403 | |
| (541) 506-6530 | |
| (541) 506-6531 |
| Full Name | Dr Matthew Labarbera |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 19 Years |
| Location | 551 Lone Pine Blvd, The Dalles, Oregon |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174728968 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peconic Bay Medical Center | Riverhead, NY | Hospital |
| Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New York University | 1355232422 | 4431 |
News Archive
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
University Behavioral Health of El Paso has opened a third floor with 40 new beds. The 18,000 square foot addition allows UBH to offer mental health and chemical dependency services to more patients in El Paso and surrounding areas.
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.
Eli Lilly and Company today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
University Behavioral Health of El Paso has opened a third floor with 40 new beds. The 18,000 square foot addition allows UBH to offer mental health and chemical dependency services to more patients in El Paso and surrounding areas.
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.
Eli Lilly and Company today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
› Verified 8 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
University Behavioral Health of El Paso has opened a third floor with 40 new beds. The 18,000 square foot addition allows UBH to offer mental health and chemical dependency services to more patients in El Paso and surrounding areas.
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.
Eli Lilly and Company today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Labarbera, MD Po Box 1520, The Dalles, OR 97058-8003 Ph: (541) 506-6530 | Dr Matthew Labarbera, MD 551 Lone Pine Blvd, The Dalles, OR 97058-9403 Ph: (541) 506-6530 |
News Archive
To better understand the signaling pathways active in sarcomas, researchers at Moffitt Cancer Center used state-of-the-art mass spectrometry-based proteomics to characterize a family of protein enzymes that act as "on" or "off" switches important in the biology of cancer. The tyrosine kinases they identified, the researchers said, could act as "drivers" for the growth and survival of sarcomas.
University Behavioral Health of El Paso has opened a third floor with 40 new beds. The 18,000 square foot addition allows UBH to offer mental health and chemical dependency services to more patients in El Paso and surrounding areas.
Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.
Eli Lilly and Company today announced it is conducting the first major international, prospective observational study designed to understand the real-world obstacles that people with type 2 diabetes face that prevent them from reaching their ultimate treatment goals.
A new study has found that endoscopic ultrasound (EUS) is associated with improved outcomes in patients with localized pancreatic cancer, possibly due to the detection of earlier cancers and improved stage-appropriate management, including more selective performance of curative intent surgery. This is the first study to analyze a large population-based cancer registry and demonstrate that EUS evaluation is associated with improved pancreatic cancer survival.
› Verified 8 days ago
Paul J Cardosi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-276-7760 Fax: 541-296-7619 | |
Dr. Jason Robert Morich, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 | |
Maile Anslinger, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 551 Lone Pine Blvd, The Dalles, OR 97058 Phone: 541-506-6920 Fax: 541-296-5451 | |
Jeanette C Paysse, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1620 E 12th St, The Dalles, OR 97058 Phone: 541-296-9151 Fax: 541-296-9156 | |
Frances May Yuhas, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 818 W 6th St Ste 4, The Dalles, OR 97058 Phone: 541-298-3747 | |
Dr. Lawrence E Long Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 E 19th St, The Dalles, OR 97058 Phone: 541-296-1111 Fax: 541-296-7601 |